LED 청색광 차단용 콘택트렌즈에 관한 연구

송대규(Dae Gyu Song),이준석(Junseok Lee),최홍진(Hong Jin Choi),김정구(Jeong Koo Kim) 한국고분자학회 2022 폴리머 Vol.46 No.1

본 연구는 사람의 안구에 황반변성과 망막 손상을 일으키는 LED digital 기기의 청색광을 차단하는 콘택트렌즈를 개발하여 효과적으로 안구보호와 황반변성 발병률을 줄이기 위하여 시도하였다. 청색광 차단재와 콘택트렌즈용 재료는 각각 coumarin과 poly-methyl-methacrylate(PMMA)이다. PMMA 용해 유기용매로 dichloromethane, chloroform, ethyl acetate, acetone, toluene을 사용하였고 이중 toluene으로 녹였을 때, 시각적인 투명도가 가장 높았고, 강도 또한 가장 높았다. 제작한 렌즈 시편의 coumarin 농도별 흡광도 측정을 통해 청색광 차단율을 확인하였다. 제작한 coumarin/PMMA 콘택트렌즈 시편의 경우 coumarin의 혼합비율에 따라 1, 2.5, 5, 10 mM에 걸쳐 325 ㎚(UV-A) 영역에서는 99% 이상의 가장 높은 차단율을 보였고, 375 ㎚ 영역에서는 1 mM일 때 5.69%, 2.5 mM은 43.34%, 5 mM은 56.45%, 10 mM은 66.25%의 결과를 보였다. 이는 청색광 차단을 위한 coumarin/PMMA 콘택트렌즈가 효과적으로 청색광을 차단하여 자연광 수준으로 낮출 수 있는 것을 알 수 있었다. This study is focused on a contact lens for shielding blue light emitted from LED digital devices, preventing macular degeneration as well as an effective protection of human eyes. For the blue light blocking lens, coumarin was used as blue light blocking material and polymethylmethacrylate (PMMA) was engaged as a material for contact lens. As a solvent for PMMA, dichloromethane, chloroform, ethyl acetate, acetone, and toluene were used and tested. Among the solvents, toluene showed the highest transparency and strength/solidity. For blue light shielding rate, coumarin was administrated with different concentration to the PMMA film, then light absorbance was measured for each specimen. In results, coumarin/PMMA films (contact lens) within 325 ㎚ (UV-A) region, all specimens, 1 mM, 2.5 mM, 5 mM, and 10 mM of coumarin contents PMMA films, showed 99% of blue light shielding rate. In case of 375 ㎚ region, each specimen showed shielding blue light as 5.69% at 1 mM, 43.34% at 2.5 mM, 56.45% at 5 mM, and 66.25% at 10 mM. Conclusively, PMMA contact lenses with coumarin contents reduced the intensity of blue light generated by LED digital devices to the level of natural light.

자궁 근종 세포에서 ATP-민감성 칼륨 통로의 동정

차순도 ( Cha Sun Do ),송대규 ( Song Dae Gyu ),조치흠 ( Jo Chi Heum ) 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.12

목적 : 본 연구는 지금까지 자궁 근종의 KATP channel 아형에 관한 연구가 없어, 자궁 근종이나 정상 자궁 근에서의 KATP channel의 존재와 아형의 종류를 확인하고, 또한 발현의 차이를 확인하고자 하였다. 연구 방법 : 자궁근종으로 전자궁 적출술을 시행하는 10예의 환자를 대상으로 자궁 근종과 인접한 정상 자궁 조직을 얻어 실험하였고, 또한 일차 세포배양을 하였다. 자궁내막의 주기는 증식기 5예와 분비기 5예로 하였다. 조직과 일차배양세 Objective : The purpose of this study was to identify the ATP-sensitive potassium (KATP) channel subtypes in uterine leiomyoma and normal myometrial cells, and to compare the difference in its expression between uterine leiomyoma and normal myometrial cel

포스터 발표 : 포스터 연제 ; 신부분절제 흰쥐에서 고염분 섭취시 심방이뇨호르몬의 변동

강문규 ( Kang Mun Gyu ),박원균 ( Park Won Gyun ),홍영수 ( Hong Yeong Su ),송대규 ( Song Dae Gyu ),배재훈 ( Bae Jae Hun ) 대한신장학회 2000 춘계학술대회 초록집 Vol.19 No.2

Melatonin이 Cisplatin에 의한 신장 독성에 미치는 영향

최혜정 ( Choe Hye Jeong ),신영호 ( Sin Yeong Ho ),문교철 ( Mun Gyo Cheol ),송대규 ( Song Dae Gyu ),김인철 ( Kim In Cheol ),서상혁 ( Seo Sang Hyeog ),곽춘식 ( Gwag Chun Sig ),장은주 ( Jang Eun Ju ),김현철 ( Kim Hyeon Cheol ) 대한신장학회 2004 Kidney Research and Clinical Practice Vol.23 No.2

목 적 : Cisplantin은 항암제로 널리 사용되나 활성산소를 생성하여 신장 기능 손상 등의 부작용이 있는 것으로 알려져 있긴 강력한 항산화제인 melatonin은 cisplatin에 의한 산장독성을 줄일 수 있을 것이다. Cisplatin에 의한 신장 독성에 대하여 melatonin의 방어 효과를 알아보고자 하였다. 방 법 : 실험군을 대조군인 제 1군, cisplatin 투여군인 제 2군 및 cisplatin과 melatonin을 투여한 제 3군으로 나눈 후 신장 조직의 형태학적 변화와 더불어 산화적 손상에 대한 연구를 수행하였으며 과산화수소, malondialdehyde 및 항산화효소의 활성도를 측정하였다. 결 과 : 혈청 BUN (p<0.001), creatinine 농도 (p<0.001) 및 신장의 과산화수소 생성량은 제 1군에 비해 제 2군에서 증가하였고, 제 2군에 비해 제 3군에서는 감소되었으며, 활성산으로 인한 손상 표지자인 malondialdehyde 농도도 같은 경향을 나타내었다. Creatinine 청소는 제 1군에 비해 제 2군에서 감소를 보였고, 제 2군에 비해 제 3군에서는 증가되었다. 신장의 superoxide dismutase 활성도는 제 1군에서 제 2군에 비해 감소하였고 catalase 활성도는 제 1군에 비해 제 2군에서 증가되었으며, 제 1군에 비해 제 3군에서는 더욱 증가되었다. Glutathione peroxidase는 통계학적으로 의미 있는 변화가 없었다. 또한 광학 현미경 소견을 보면 제 2군의 사구체에서는 특이한 변화가 없었으나, 근위 곱슬 세관은 심한 괴사를 나타내었고, 제 3군의 근위 곱슬 세관에서 중등도의 괴사를 나타내었으며 제 2군보다 경한 변화를 보였다. 결 론 : Cisplatin은 신장에서 superoxide dismutase 활성도 증가와 catalase의 활성도를 저하시켜 과산화수노의 생성을 유도하여 신장 손상을 유발하는 것으로 생각되며, melatonin은 superoxide dismutase 활성도 증가와 catalase 활성도 증가를 유도하여 cisplatin에 의해 유발된 신장 손상을 줄이는 것으로 생각된다. Background : Cisplatin (CP), an antitumor agent widely used in the treatment of cancers, has nephrotoxicity. This side effect is closely related to oxidative stress. In the present study, we attempted to reduce CP-induced nephrotoxicity in rats by administering melatonin, an antioxidant. Methods : Male Sprague-Dawley rats were divided into different groups and were treated as follows : ⑴ saline control; ⑵ CP (16 mg/kg, i.p.); ⑶ CP plus melatonin (10 mg/kg, i.p.). The rats were sacrificed at the 6th day after CP treatment. To evaluate renal damage, BUN, serum creatinine, creatinine clearance and microscopic examination were done. Hydrogen peroxide which is one of the oxygen free radicals, and malondialdehyde which is known as a marker of the oxygen free radical mediated injury, and the activities of the antioxidant enzymes such as superoxied dismutase, catalase, and glutathione peroxidase were also measured. Results : CP-treated rats showed the increase of BUN, serum creatinine, malondialdehyde, hydrogen peroxide and superoxide dismutase (SOD) in kidney. And CP-treated rats also showed the decrease of creatinine clearance and catalase levels. CP-treated rats showed severe tubular necrosis in proximal convoluted tubules under the light microscopic examination. The light microscopic finding and all of the parameters except SOD were restored in the rats injected with CP plus melatonin than those with CP alone. SOD level was higher in the rats injected with CP plus melatonin than that with CP alone. Conclusion : These results suggest that melatonin suppresses CP-induced nephrotoxicity by suppressing the production of reactive oxygen species via the activation of SOD and catalase. (Korean J Nephrol 2004;23(2):205-212)

만성신부전 쥐에서 심방 및 심방외 조직 ANP mRNA의 발현

홍영수,배재훈,이원기,박원균,송대규 대한신장학회 2000 Kidney Research and Clinical Practice Vol.19 No.5

Chronic renal failure(CRF) may lead to fluid retention and electrolyte imbalance, and consequently increases the extracellular volume and blood pressure. These changes can trigger secretion and synthesis of atrial natriuretic peptide(ANP) as a compensatory regulator for increases in the glomerular filtration rate and excretion of water and sodium due to the reduced number of functional nephrons. ANP may exert important regulatory role on body fluid balance and blood pressure in CRF. We assessed changes in gene expression of atrial and extra-atrial ANP associated with progression of renal failure in subtotal nephrectomized rats. Adult male Sprague-Dawley rats were divided into sham and CRF rats. CRF rats were induced by 5/6 subtotal nephrectomy. We determined the plasma ANP level using by radioimmunoassay and the ANP mRNA from the right atrium, left ventricle, hypothalamus and kidney were rneasured by reverse transcription-polymerase chain reaction with P-dCTP at 8 wk in sham, and at 8 and 12 wk in CRF rats. Serum urea nitrogen(SUN) was also checked as an indicator of impaired renal function. SUN was significantly increased in CRF rats and the level was higher at CRF 12 wk rat than CRF 8 wk rat. Plasma concentration of ANP also increased in CRF rats compared with sham rat, but was not statistically significant. Altered patterns of ANP mRNA expression were different in each tissue. Right atrial and renal ANP mRNA expressions were slightly increased in CRF rats. Left ventricular ANP mRNA was significantly increased in CRF 8 wk rat compared with sham rat and maintained high at CRF 12 wk rat. However hypothalamic ANP mRNA expressions at CRF rats were decreased and the expression in CRF 12 wk was significantly lower than that at CRF 8 wk. SUN showed positive correlations with expression in left ventricular and renal ANP mRNA, but had a significant negative relationship with hypothalamic ANP mRNA. Plasma ANP concentration was positively correlated with the ANP mRNA expressions in both right atrium and kidney. The present study demonstrated that ANP mRNA in the right atrium, left ventricle, kidney and hypothalamus were differentially expressed upon CRF. This suggests that roles of the local ANP in these tissues are regulated by different mechanisms to compensate the fluid and electrolyte imbalance in rats with experimental chronic renal failure.